About
Xterna develops therapeutics that utilize engineered xeno nucleic acid-based molecules called XENAs to target and deliver drugs to hard-to-reach tissues within the human body, improving drug efficacy and reducing toxicity.
Explore Xterna's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.